BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 24425780)

  • 1. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany.
    Herlyn K; Buckert F; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2014 May; 53(5):882-9. PubMed ID: 24425780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway.
    Nilsen AT; Karlsen C; Bakland G; Watts R; Luqmani R; Koldingsnes W
    Rheumatology (Oxford); 2020 Sep; 59(9):2316-2324. PubMed ID: 31859355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies.
    Romero-Gómez C; Aguilar-García JA; García-de-Lucas MD; Cotos-Canca R; Olalla-Sierra J; García-Alegría JJ; Hernández-Rodríguez J
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-11-8. PubMed ID: 25437862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany.
    Reinhold-Keller E; Zeidler A; Gutfleisch J; Peter HH; Raspe HH; Gross WL
    Rheumatology (Oxford); 2000 Dec; 39(12):1396-402. PubMed ID: 11136884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
    Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
    Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothyroidism in vasculitis.
    Kermani TA; Cuthbertson D; Carette S; Khalidi NA; Koening CL; Langford CA; McAlear CA; Monach PA; Moreland L; Pagnoux C; Seo P; Specks U; Sreih A; Warrington KJ; Merkel PA;
    Rheumatology (Oxford); 2022 Jul; 61(7):2942-2950. PubMed ID: 34730828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method.
    Rubenstein E; Henneton P; Rivière S; Casanova ML; Broner J; Arnaud E; Oziol E; Le Quintrec M; Moranne O; Jorgensen C; Combe B; Bourdin A; Fontaine C; Schiffmann A; Fraison JB; Hallé O; Fraisse T; Veysseyre F; Taieb G; Aerts C; Crampette L; Alovisetti C; Guis L; Mehlal S; Papinaud L; Le Quellec A; Guilpain P; Mahr A
    Rheumatology (Oxford); 2024 May; 63(6):1552-1559. PubMed ID: 37819770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.
    Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S
    Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan.
    Kobayashi S; Fujimoto S; Takahashi K; Suzuki K
    Kidney Blood Press Res; 2010; 33(6):442-55. PubMed ID: 21071954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.
    Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gross WL
    Arthritis Rheum; 2005 Feb; 53(1):93-9. PubMed ID: 15696553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granulomatous vasculitides and vasculitides with extravascular granulomatosis].
    Arnold S; Klapa S; Holl-Ulrich K; Müller A; Kerstein-Stähle A; Lamprecht P
    Z Rheumatol; 2022 Sep; 81(7):558-566. PubMed ID: 35962194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey.
    Pamuk ÖN; Dönmez S; Calayır GB; Pamuk GE
    Clin Rheumatol; 2016 Aug; 35(8):2063-2071. PubMed ID: 26992904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does geographic location affect incidence of ANCA-associated renal vasculitis in northern Saskatchewan, Canada?
    Anderson K; Klassen J; Stewart SA; Taylor-Gjevre RM
    Rheumatology (Oxford); 2013 Oct; 52(10):1840-4. PubMed ID: 23838025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study.
    Bischof A; Jaeger VK; Hadden RDM; Luqmani RA; Pröbstel AK; Merkel PA; Suppiah R; Craven A; Collins MP; Daikeler T
    Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31540965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibody-associated vasculitis in Taiwan: A hospital-based study with reference to the population-based National Health Insurance database.
    Wu CS; Hsieh CJ; Peng YS; Chang TH; Wu ZY
    J Microbiol Immunol Infect; 2015 Oct; 48(5):477-82. PubMed ID: 24560699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and Clinical Features of ANCA-Associated Vasculitides in a Peruvian Tertiary Center.
    Pimentel-Quiroz VR; Sánchez-Torres A; Acevedo-Vásquez E; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Medina-Chinchón M; Zevallos F; Noriega-Zapata E; Alfaro-Lozano J; Cucho-Venegas JM; Sánchez-Schwartz C; Rodríguez-Bellido Z; Perich-Campos R; Pastor-Asurza CA; Alarcón GS; Ugarte-Gil MF
    J Clin Rheumatol; 2021 Sep; 27(6S):S246-S251. PubMed ID: 33044385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases.
    Sreih AG; Annapureddy N; Springer J; Casey G; Byram K; Cruz A; Estephan M; Frangiosa V; George MD; Liu M; Parker A; Sangani S; Sharim R; Merkel PA;
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1368-1374. PubMed ID: 27804171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patients.
    Arnold S; Wallmeier P; Tais A; Ihorst G; Janoschke M; Schubach F; Aries P; Bergner R; Bremer JP; Görl N; Gutdeutsch E; Hellmich B; Henes J; Hoyer BF; Kangowski A; Kötter I; Krusche M; Magnus T; Metzler C; Müller-Ladner U; Petersen J; Reichelt de Tenorio A; Schaier M; Schirmer JH; Schönermarck U; Thiel J; Unger L; Venhoff N; Weinmann-Menke J; Iking-Konert C; Lamprecht P
    Clin Exp Rheumatol; 2024 Apr; 42(4):852-858. PubMed ID: 38607682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study.
    Hellmich B; Lamprecht P; Spearpoint P; Götte D; Deichmann A; Buchholz I; Schönermark MP; Rutherford P
    Rheumatology (Oxford); 2021 Oct; 60(10):4868-4873. PubMed ID: 33501936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden.
    Mossberg M; Segelmark M; Kahn R; Englund M; Mohammad AJ
    Scand J Rheumatol; 2018 Jul; 47(4):295-302. PubMed ID: 29409373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.